Susquehanna International Group’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Sell
447,000
-24,700
-5% -$94K ﹤0.01% 6779
2025
Q4
$1.64M Buy
471,700
+202,900
+75% +$903K ﹤0.01% 6055
2025
Q3
$1.49M Buy
268,800
+226,900
+542% +$922K ﹤0.01% 6429
2025
Q2
$103K Buy
41,900
+20,600
+97% +$31.8K ﹤0.01% 11779
2025
Q1
$42.4K Sell
21,300
-5,100
-19% -$13K ﹤0.01% 11913
2024
Q4
$77.1K Sell
26,400
-33,500
-56% -$118K ﹤0.01% 11492
2024
Q3
$232K Buy
59,900
+12,900
+27% +$59.8K ﹤0.01% 10160
2024
Q2
$242K Buy
47,000
+31,600
+205% +$192K ﹤0.01% 9938
2024
Q1
$108K Buy
15,400
+3,100
+25% +$23.5K ﹤0.01% 11173
2023
Q4
$109K Buy
+12,300
New +$94.8K ﹤0.01% 11256

Other funds holding PRME